To subscribe to our optical e-newsletters and receive them via e-mail, click here.
What we know about mucins and their role in protecting the eye from ocular surface disease.
This disease is linked to vision loss, hearing loss and cataract. Learning more about it may help lead to better treatments.
Highlights from the posters and papers presented at the 2014 ARVO meeting in Orlando.
Antibiotic innovation has slowed, allowing drug resistance to catch up, but there is still hope for the future of anti-infectives.
A look at the processes of immunity and ocular inflammation, and new avenues for disease therapy.
How different drug formulations and dosing regimens may help ensure that patients take their medicine.
Continued exposure to an antigen may overcome an allergy, but there are still hurdles to clear before this approach is common.
A look at the value and utility of a range of diagnostic techniques and technology for anterior segment disease.
When a patient is taking drugs systemically, here are the ocular adverse events to be on the lookout for.
A breakdown of the corneal nerves, how they’re stimulated and how dry eye, trauma and contact lenses affect them.
Copyright© 2000 - 2014 Jobson Medical Information LLC unless otherwise noted.
All rights reserved. Reproduction in whole or in part without permission is prohibited.